Ras-induced transformation is characterized not only by uncontrolled proliferation but also by drastic morphological changes accompanied by the disruption of the actin cytoskeleton. Previously, we reported that human fibroblasts are more resistant than rodent fibroblasts to Rasinduced transformation. To explore the molecular basis for the difference in susceptibility to Ras-induced transformation, we investigated the effect of activated H-Ras on the actin cytoskeleton in human diploid fibroblasts and in rat embryo fibroblasts, both of which are immortalized by SV40 early region. We demonstrate here that Ras-induced morphological changes, decreased expression of tropomyosin isoforms, and suppression of the ROCK/LIMK/Cofilin pathway observed in the rat fibroblasts were not detected in the human fibroblasts even with high expression levels of Ras. We also show that activation of the MEK/ERK pathway sufficed to induce all of these alterations in the rat fibroblasts, whereas the human fibroblasts were refractory to these MEK/ERKmediated changes. In addition to morphological changes, we demonstrated that the expression of activated Ras induced an invasive phenotype in the rat, but not in the human fibroblasts. These studies provide evidence for the existence of human-specific mechanisms that resist Ras/MEK/ERK-mediated transformation.
Introduction
Much of our understanding of oncogenic transformation is derived from the study of avian and rodent cells. There is no doubt regarding the substantial importance of these cell systems to the study of oncogenic transformation. However, increasing evidence suggests that there are fundamental differences between human cells and cells from other species with respect to the process of transformation. In contrast to rodent cells, human cells are well documented to be highly resistant to oncogenic transformation. In recent years, telomerase has emerged as a candidate that can explain such a species difference in transformability. Most human somatic cells tightly downregulate telomerase expression, whereas rodent somatic cells express telomerase constitutively and therefore circumvent the telomerebased senescence, one of the major constraints on oncogenic transformation. In 1999, Weinberg and colleagues reported that the ectopic expression of the catalytic subunit of human telomerase (hTERT) made normal human cells susceptible to transformation by the combination of SV40 early region (ER, encoding large as well as small T antigens) and activated Ras (Hahn et al., 1999) . Even when all these requirements are fulfilled, however, our recent study demonstrated that transformed phenotypes in human cells were extremely limited relative to those observed in rodent cells with regard to anchorage independence and tumorigenicity (Akagi et al., 2003) . This strongly suggests that human cells have still undefined protective mechanisms, other than the suppression of telomerase, against malignant transformation.
It has been well documented that Ras-transformed cells undergo drastic morphological changes accompanied by disruption of the actin cytoskeleton and decreased focal adhesions. These changes in the structure of the actin cytoskeleton correlate well with both anchorage-independent growth and cellular tumorigenicity, suggesting critical roles for actin filaments in oncogenic transformation. Therefore, much attention has been focused on investigating how structural components of the actin cytoskeleton contribute to changes in microfilament assembly and how changes in these proteins might contribute to alterations in growth control and tumorigenesis (Pawlak and Helfman, 2001 ).
To date, most studies on Ras-induced morphological changes have been performed by using rodent fibroblasts, such as NIH3T3 or NRK cells. From these studies, it has been learned that alterations in actin filaments in Ras-transformed cells correlate with decreased expression of various cytoskeletal proteins such as vinculin (Rodriguez Fernandez et al., 1992) , a-actinin (Gluck et al., 1993) , gelsolin (Tanaka et al., 1995) , profilin-1 (Janke et al., 2000) , and the high-molecular-weight tropomyosin (TM) isoforms (Hendricks and Weintraub, 1981; Janssen et al., 2003; Shields et al., 2002) . So far, however, very few studies have analysed the effect of activated Ras on the morphology of human fibroblasts. In this study, we comparatively analysed the morphological changes induced by activated Ras between human diploid fibroblasts (HDF) immortalized by SV40 ER plus hTERT and rat embryo fibroblasts (REF) immortalized by SV40 ER. We report here that HDF are much more resistant than REF against Rasinduced cytoskeletal changes even at high expression levels of activated H-Ras, providing further evidence for the refractory nature of human cells against oncogenic transformation.
Results
Human diploid fibroblasts (HDF) are resistant to morphological changes upon the introduction of H-Ras V12 (activated H-Ras)
We first compared the effects of H-Ras V12 (activated H-Ras) on the cell morphology of HDF and of REF. (Figure 1a ). We present the data for TIG3 cells as an example, but several other human fibroblasts examined (IMR90, MRC5, and BJ) showed similar results (data not shown). In REF expressing both SV40 ER and H-Ras V12 (REF/SR), the stress fiber formation and focal adhesion contact were totally absent, as reported for many other Ras-transformed rodent fibroblast cell lines. In contrast, TIG3/TS cells expressing H-Ras V12 (TIG3/TSR) showed no disruption of stress fiber formation or of focal adhesion contacts (Figure 1b 
Activated Ras does not downregulate high-molecularweight TM isoforms in HDF
TMs are a family of actin-binding proteins that stabilize the organization of microfilaments and are expressed with a high degree of tissue specificity (Pawlak and Helfman, 2001) . TMs can be categorized into highand low-molecular-weight isoforms. In nonmuscle cells, such as fibroblasts and epithelial cells, multiple HMW isoforms are expressed, which are referred to as TM1, TM2, and TM3. A number of studies have demonstrated the downregulation of HMW isoforms of TM (TM1 and TM2) in transformed cells including Rastransformed fibroblasts (Hendricks and Weintraub, 1981; Matsumura et al., 1983; Janssen et al., 2003; Raval et al., 2003) . Moreover, it has been reported that re-introduction of TM1 or TM2 into Ras-transformed cells results in reorganization of the actin cytoskeleton and suppression of anchorage independence and tumorigenicity (Gimona et al., 1996; Shah et al., 2001) . Given the importance of HMW isoforms of TMs in oncogenic transformation, we analysed the expression of these 
De-phosphorylation of cofilin fails to occur in HDF upon the introduction of activated Ras
In addition to the involvement of cytoskeletal proteins such as TMs, organization of microfilaments is under the control of the Rho subfamily of small GTPases, that is, Rho, Rac, and Cdc42 (Bishop and Hall, 2000) . Among these small GTPases, Rho is involved in the assembly of actin stress fibers and focal contacts through activation of mDia and kindred kinase ROCKI/Rho-kinase (Amano et al., 1997; Watanabe et al., 1999) . Activation of ROCK by Rho leads to the activation of LIMK, which subsequently phosphorylates cofilin at its Ser3, thereby inhibiting its actindepolymerizing activity and thus contributing to the stabilization of actin stress fiber (Yang et al., 1998; Maekawa et al., 1999) . To gain more insight into the difference in H-Ras V12-induced morphological changes between HDF and REF, we examined the phosphorylation state of cofilin by immunoblot analysis. Cofilin was almost completely de-phosphorylated at its Ser 3 in REF/SR. However, this de-phosphorylation failed to occur in TIG3/TSR or other human TSRs, despite the even higher expression level of H-Ras V12 in these cells than in REF/SR (Figure 3a ). Since cofilin is (Figure 3c ). Several studies reported that Ras-transformed cells showed an elevated level of the active GTP-bound form of Rho, but that Rho activation was not coupled to the downstream ROCK/LIMK activation. The proposed mechanisms for this uncoupling differ depending on the reports. One study using Swiss-3T3 cells showed that ROCK was largely translocated away from the cell fraction in which Rho was found upon Ras-induced transformation (Sahai et al., 2001) . In another study using NRK cells, expression of ROCK was reported to be downregulated through a post-transcriptional mechanism by H-Ras V12 (Pawlak and Helfman, 2002) . It has also been reported that an elevated level of cytoplasmic p21
Cip1 results in the formation of a physical complex with ROCK that inhibits ROCK activity in Ras-transformed NIH3T3 cells (Lee and Helfman, 2004) . In our system, the REF/SR showed slightly increased level of active Rho (Figure 3b ), which is consistent with previous findings. However, neither the localization nor the expression level of ROCK was changed in response to H-Ras V12 (data not shown). Moreover, sequestration of ROCK by p21 Cip1 seems to be unlikely because the expression level of p21
Cip1 remained low even after the expression of H-Ras V12, probably due to the inactivation of p53 by SV40 large T antigen in our system. We further confirmed that activated Ras-induced cytoplasmic localization of p21
Cip1 was not apparent in our system (data not shown). However, whatever the mechanism is, our results clearly demonstrate that the ROCK/LIMK/Cofilin pathway is inhibited by activated Ras in REF but not in HDF.
Activated Ras was unable to induce HDF to invade extracellular matrix (ECM)
Since the actin cytoskeleton plays an important role in the regulation of cellular processes linked to metastasis, cell invasion, and migration (Pawlak and Helfman, 2001; Jaffe and Hall, 2002) , we performed an invasion assay using the BioCoat Matrigel Invasion Chamber. Expression of H-Ras V12 strongly induced REF/S cells to invade the ECM, a result that is consistent with previous reports on studies using rodent fibroblast cell lines such as NIH3T3 (Campbell and Der, 2004 ; Figure 4a ). In marked contrast, TIG3/TS cells did not become invasive upon the expression of H-Ras V12. Concomitantly, gelatin zymography revealed that the activity of matrix metalloproteinase-9 (MMP-9), which degrades ECM to allow invasion, was significantly increased in REF/S cells, but not in TIG3/TS, in response to H-Ras V12. These results demonstrate that expression of activated Ras is sufficient to induce invasive phenotype in REF/S cells, but that TIG3/TS cells are highly resistant to this Ras-induced invasiveness.
Activation of MEK/ERK signaling pathway induces disruption of the actin cytoskeleton in rat fibroblasts but not in human fibroblasts
To elucidate the molecular mechanisms underlying the different responses to activated Ras in terms of cell morphologies between human and rat fibroblasts, we first tried to identify the signaling pathway responsible for the Ras-induced disruption of the actin cytoskeleton in rat fibroblasts. For that, we examined the effect of pharmacological inhibitors of two major signaling pathways activated by Ras, that is, the MEK/ERK pathway and phosphatidylinositol 3-kinase (PI3 K)/Akt pathway. Upon treatment with a MEK inhibitor (U0126) for 48 h, REF/SR cells underwent clear morphological reversion, exhibiting well-developed actin stress fibers and focal adhesions (Figure 5a ), whereas a PI3K inhibitor (LY294002) had no effect on the cell morphology (data not shown). Accompanied with this morphological reversion, we found that treatment with U0126 restored both the downregulated HMW isoforms of TM and the phosphorylation of cofilin at Ser 3 in REF/SR cells (Figure 5c) . These results clearly demonstrate that (Figure 5b and c) . These results indicate that activation of the MEK/ERK pathway is necessary and sufficient for the morphological changes accompanied by disorganization of the actin cytoskeleton in the rat fibroblasts. Addition to the morphological changes, rasinduced invasiveness as well as the gene expression of MMP-9 were well inhibited by the treatment with the MEK inhibitor (Supplementary Figure 1) , suggesting the ras-induced invasiveness could also be mediated by the MEK/ERK pathway.
Given the primary importance of the MEK/ERK pathway in Ras-induced morphological alterations, the activation of MEK/ERK pathway by H-Ras V12 might be attenuated in human fibroblasts. Therefore, we examined the activation status of MEK and ERK in TIG3/TSR by immunoblotting with antibodies specific for phosphorylated Ser 221/227 of MEK and phosphorylated Ser 217/221 of ERK. Unexpectedly, however, similar activation of both MEK and ERK was observed in TIG3/TSR (and other human TSRs) and REF/SR (Figure 6 ), indicating that, in contrast to rat fibroblasts, human fibroblasts did not show the cytoskeletal alterations even with the activated MEK and ERK. In support of this notion, we observed no significant morphological changes accompanied by the disruption of stress fiber and focal contact formation, downregulation of TM isoforms or dephosphorylation of cofilin in TIG3/TS cells expressing LA-SDSE MEK (Figure 5b and c) . These results strongly suggest that the difference between rat and human fibroblasts in the signaling pathway regulating cytoskeletal organization exists downstream of ERK.
Discussion
In this study, to explore the mechanism underlying the reported difference in susceptibility to Ras-induced transformation between rat and human fibroblasts (Akagi et al., 2003) , we focused on the morphological changes and investigated the effect of activated Ras on the actin cytoskeleton in HDF/TS and REF/S. We first demonstrated that HDF/ TS cells were highly resistant to the Ras-induced disruption of actin stress fiber and decrease in focal adhesions, which are common features following the transformation of rodent fibroblasts by many kinds of oncogenes. Decreased expression of the HMW isoforms of TM and suppression of the ROCK/LIMK/Cofilin pathway are well documented to be critically involved in Ras-induced morphological Here, we clearly demonstrated that neither of these phenomena was observable in HDF/TSR. Downregulation of the HMW isoforms of TM is commonly observed not only in rodent cells transformed by many kinds of oncogenes, but also in human patientderived squamous, breast, ovary, and prostate carcinomas (Gabbiani et al., 1976; Wang et al., 1996; Alaiya et al., 1997) . In addition, reduced TMs levels have also been correlated with metastatic potential in lung carcinoma and melanoma cells (Takenaga et al., 1988; Hashimoto et al., 1996) . Although the downregulation of TM in Ras-transformed cells has been repeatedly described, the underlying mechanisms are not yet well understood. One study reported this downregulation to be independent of MEK (Janssen et al., 1998) , but another one reported that it is at least partially dependent on MEK (Shields et al., 2002) . Our results using MEK inhibitors as well as a constitutively active MEK mutant clearly demonstrated that the transcriptional downregulation of TMs in the REF/SR cells was totally dependent on the MEK/ERK pathway. However, we could not detect any significant differences in the activation of MEK/ERK pathway between rodent and human fibroblasts expressing activated Ras, as judged from the phosphorylation status of these kinases. Recently, Janssen et al. (2003) reported that overexpression of kinase suppressor of Ras (KSR) 1 restores TM expression in Ras-transformed NIH3T3 cells without inhibiting MEK and ERK phosphorylation. Their report thus shows another possibility to repress the signaling pathway regulating TM expression without changing the phosphorylation status of MEK/ERK. In another study, TM expression was upregulated by TGF-b/Smad signaling (Bakin et al., 2004) , and it has been shown that Smad is inactivated by oncogenic Ras through the MEK/ERK pathway (Kretzschmar et al., 1999; Saha et al., 2001) . Smad, therefore, might be a transcriptional factor responsible for the expression of TMs regulated differentially in rat and human fibroblasts as a downstream mediator of the MEK/ERK pathway. There is an intriguing possibility that Rasinduced suppression of TGF-b/Smad signaling does not occur in human fibroblasts as efficiently as in rat fibroblasts. In any case, more details about the mechanism underlying the downregulation of TMs in Ras-transformed rat cells must be forthcoming to understand better the differences between human and rat cells.
Suppression of the ROCK/LIMK/Cofilin pathway is reported to play an important role in the cytoskeletal disruption observed in Ras-transformed rodent fibroblasts, and several mechanisms have been proposed for this suppression (Sahai et al., 2001; Pawlak and Helfman, 2002) . However, none of them can explain the strong suppression of this pathway observed in our REF/SR cells. Our results clearly show the primary importance of the MEK/ERK pathway in this suppression and indicate that human fibroblasts are totally resistant to this MEK/ERK-mediated inhibition of the ROCK/LIMK/Cofilin pathway despite the presence of MEK and ERK, whose phosphorylation status is almost the same as that in rat fibroblasts. Taken together with the results on TMs, this observation raises the possibility that decisive difference between rat and human fibroblasts in the signaling pathway regulating cell morphology exists downstream of ERK. Meanwhile, we must yet examine more carefully whether there are any significant differences in the activation state of MEK and ERK between human and rodent cells by analysing their properties other than phosphorylation, for example, actual enzymatic activities or subcellular distribution. Human cells might have more efficient negative-feedback mechanisms to prevent overactivation of the MEK/ERK pathway than rodent cells. Although, besides Raf/MEK/ERK pathway, phosphoinositide 3-kinases (PI3Ks) and RalGDS are the well-characterized downstream effectors involved in rasinduced transformation, the activation of Raf/MEK/ ERK pathway alone is sufficient to cause morphological changes in our experiments using rat fibroblasts. Investigation into the species difference in the regulation of the Raf/MEK/ERK kinase cascade is becoming a focus of our current research.
In this study, we have distinctly demonstrated that human fibroblasts are more resistant to Ras-induced morphological changes than rodent fibroblasts. In addition to the morphological changes caused by activated Ras, we also demonstrated that its expression could induce the invasive phenotype in rat fibroblasts, whereas invasiveness was hardly induced in human fibroblasts by activated Ras. All of these data highlight the strong resistivity of human fibroblasts toward Rasinduced transformation, and suggest the existence of still undefined human-specific, cell-autonomous mechanisms rendering them resistant to malignant transformation. We still do not know the means by which we can transform human fibroblasts to become as malignant Resistance to Ras-induced morphological changes T Sukezane et al as rodent fibroblasts. Considering that aberrations in the actin cytoskeleton are closely correlated with malignant phenotypes, further investigation of the molecular mechanisms underlying the differences in activated Ras-induced cytoskeletal changes observed in human and rat fibroblasts should provide profound insight into the molecular basis of the human-specific antitransformation mechanisms.
Materials and methods

Cells and cell culture
Human diploid fibroblasts, that is, TIG3, IMR90, BJ, and MRC5 (obtained from ATCC), and rat embryo fibroblasts were cultured in DMEM supplemented with 10% FBS as described previously (Akagi et al., 2003) . In some experiments, cells were treated with MAP kinase kinase (MAPKK/ MEK) inhibitor U0126 (Sigma) as described in the figure legends.
Retroviral-mediated gene transfer
All the gene transfer experiments were carried out by using retroviral vector. Retroviral vectors encoding SV40 T early region (including small t and large T antigens), hTERT (human telomerase catalytic subunit), and H-ras V12 (activated form of H-ras) were described previously (Akagi et al., 2003) . cDNA of LA-SDSE MEK (MAPKK), a constitutively active mutant of mek, was generously provided by Dr Nishida of Kyoto University (Fukuda et al., 1997) and subcloned into CX4bleo. Production of and infection with retroviral vectors were performed as described previously (Akagi et al., 2003) . The expression plasmid coding for human LIMK1 was constructed by PCR amplification of the human LIMK1 cDNA using 5 0 primer 5 0 -gagtgcatgaggttgacgctac and 3 0 primer 5 0 -gctcagtcggggacctcagg, and subcloned into CX4bleo.
Immunoblot analysis
Immunoblot analysis was performed as indicated earlier (Akagi et al., 2000) . Mouse monoclonal antibodies against vincullin (V4505) and TM (TM 311) were obtained from Sigma. Rabbit polyclonal antibodies specific for phospho-MAP kinase (ERK1/2), phospho-MEK 1/2 (Ser217/221), MEK 1/2, phospho-LIMK1/2 (Thr508/505), phospho-cofilin (Ser3), and cofilin were obtained from Cell Signaling Technology. Rabbit polyclonal antibody against MAP kinase (ERK1/2 CT) was obtained from Upstate. Mouse monoclonal antibody specifically recognizing Ras was obtained from Transduction Laboratories.
RT-PCR
Total RNA was extracted by using an RNeasy Midi Kit (Qiagen) according to the manufacturer's directions. Total RNA (0.2 mg) was used for RT-PCR. The expression of the a-tm gene was analysed by RT-PCR using the forward primer described by Gimona et al. (1995) and 5 0 -tcacatgttgtttagctc cagtaaa-3 0 as the backward primer. The expression of a housekeeping gene, gapdh, was used for verification of input total RNA by amplifying it with the following primers: 5 0 -tgaacgggaagcactgg-3 0 and 5 0 -tccaccaccctgttgctgta-3 0 . PCR products were electrophoresed in a 1.0% agarose gel and visualized by ethidium bromide staining.
Immunofluorescence microscopy
Cells (5 Â 10 3 /well) were grown in media containing 10% FBS on poly-D-lysine-coated eight-well CultureSlides (Becton Dickinson) for 24 h or treated with 25 mM U0126 for 48 h before they were fixed in 2.0% paraformaldehyde. Cells were permeabilized by incubating them for 10 min with 0.5% NP-40 in PBS and then incubated with primary and secondary antibodies, each diluted in PBG (0.2% cold water fish gelatin and 0.5% BSA in PBS). Incubation with primary and secondary antibodies was carried out at room temperature for 2 and 1 h, respectively, and the cells were rinsed with PBG after incubation with each antibody. Alexa Fluor 488-labelled goat anti-mouse IgG (Molecular Probes) was used as the secondary antibody. After a final rinse with PBG, culture slides were mounted with 50% glycerol in PBS. Cells were visualized by using a confocal laser scanning microscope (model 510; Carl Zesis, Oberkochen, Germany).
Cell invasion assay
This assay was performed by using the BD BioCoat Matrigel Invasion Chamber (Becton Dickinson) according to the manufacturer's directions. Cells that had invaded the Matrigel were quantified by counting the average number of stained cells in four separate visual fields under the microscope at Â 100 magnification.
Gelatin zymography
Culture supernatants were prepared from cells (5 Â 10 5 /60-mm culture dish) that had been incubated in DMEM containing 0.1% BSA (Takahashi et al., 1998) at 371C for 12 h. Each supernatant was separated, without prior boiling, by electrophoresis through an SDS/polyacrylamide (8%) gel containing 1 mg/ml gelatin under nonreducing conditions. The proteins in the gel were renatured and activated by washing the gel two times (20 min each time) with 0.2% Triton X-100 at room temperature followed by incubation of the gel in activation buffer (10 mM Tris (pH 7.5) containing 1.25% Triton X-100, 5 mM CaCl 2 , 1 mM ZnCl 2 ) overnight at 371C. The gel was stained with Quick-CBB (Wako) by following the manufacturer's instructions.
Rho-GTP pulldown assay
The level of Rho-GTP was measured by affinity precipitation using Rhotekin-RBD Rho Activation Assay Kit (Cytoskeleton) following manufacturer's instructions. Precipitated Rho-GTP was detected by immunoblot analysis using a monoclonal anti-RhoA antibody (Santa Cruz Biotechnology).
